CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C13404 | BRD-K34673456 | BRD-K34673456 | -- | -- | -- | Details |
C13405 | BRD-K34673904 | BRD-K34673904 | -- | -- | -- | Details |
C13406 | BRD-K34677894 | BRD-K34677894 | -- | -- | -- | Details |
C13407 | BRD-K34684441 | BRD-K34684441 | -- | -- | -- | Details |
C13408 | BRD-K34685430 | BRD-K34685430 | -- | -- | methylergometrine | Details |
C13409 | BRD-K34688736 | BRD-K34688736 | -- | -- | -- | Details |
C13410 | BRD-K34692511 | BRD-K34692511 | -- | -- | -- | Details |
C13411 | BRD-K34695725 | BRD-K34695725 | -- | -- | -- | Details |
C13412 | BRD-K34700473 | BRD-K34700473 | -- | -- | -- | Details |
C13413 | BRD-K34701680 | BRD-K34701680 | -- | -- | -- | Details |
C13414 | BRD-K34703146 | BRD-K34703146 | -- | -- | -- | Details |
C13415 | BRD-K34710061 | BRD-K34710061 | -- | -- | -- | Details |
C13416 | BRD-K34711351 | BRD-K34711351 | -- | -- | -- | Details |
C13417 | BRD-K34713073 | PD-123319 | AGTR2 | Angiotensin antagonist | -- | Details |
C13418 | BRD-K34720817 | BRD-K34720817 | -- | -- | -- | Details |
C13419 | BRD-K34721572 | BRD-K34721572 | -- | -- | -- | Details |
C13420 | BRD-K34722304 | MK-801 | -- | -- | -- | Details |
C13421 | BRD-K34730083 | BRD-K34730083 | -- | -- | -- | Details |
C13422 | BRD-K34730807 | levodopa | DRD3 | Dopamine precursor | -- | Details |
C13423 | BRD-K34737616 | BRD-K34737616 | -- | -- | -- | Details |
C13424 | BRD-K34739003 | BRD-K34739003 | -- | -- | -- | Details |
C13425 | BRD-K34739404 | BRD-K34739404 | -- | -- | -- | Details |
C13426 | BRD-K34741587 | BRD-K34741587 | -- | -- | -- | Details |
C13427 | BRD-K34741779 | SA-1459187 | -- | -- | -- | Details |
C13428 | BRD-K34747076 | BRD-K34747076 | -- | -- | -- | Details |
C13429 | BRD-K34755514 | BRD-K34755514 | -- | -- | -- | Details |
C13430 | BRD-K34758135 | BRD-K34758135 | -- | -- | -- | Details |
C13431 | BRD-K34761198 | BRD-K34761198 | -- | -- | -- | Details |
C13432 | BRD-K34766381 | BRD-K34766381 | -- | -- | -- | Details |
C13433 | BRD-K34776109 | glimepiride | KCNJ11; ABCC8 | Insulin secretagogue | -- | Details |
C13434 | BRD-K34781184 | BRD-K34781184 | -- | -- | -- | Details |
C13435 | BRD-K34786682 | BRD-K34786682 | -- | -- | -- | Details |
C13436 | BRD-K34787855 | BRD-K34787855 | -- | -- | -- | Details |
C13437 | BRD-K34797601 | BRD-K34797601 | -- | -- | -- | Details |
C13438 | BRD-K34798063 | BRD-K34798063 | -- | -- | -- | Details |
C13439 | BRD-K34798777 | BRD-K34798777 | -- | -- | -- | Details |
C13440 | BRD-K34798837 | BRD-K34798837 | -- | -- | -- | Details |
C13441 | BRD-K34799054 | BRD-K34799054 | -- | -- | -- | Details |
C13442 | BRD-K34800739 | BRD-K34800739 | -- | -- | -- | Details |
C13443 | BRD-K34801930 | AZD-5069 | -- | -- | -- | Details |
C13444 | BRD-K34804325 | BRD-K34804325 | -- | -- | -- | Details |
C13445 | BRD-K34808207 | BRD-K34808207 | -- | -- | -- | Details |
C13446 | BRD-K34810022 | BRD-K34810022 | -- | -- | -- | Details |
C13447 | BRD-K34811324 | BRD-K34811324 | -- | -- | -- | Details |
C13448 | BRD-K34812979 | BRD-K34812979 | -- | -- | -- | Details |
C13449 | BRD-K34815008 | BRD-K34815008 | -- | -- | -- | Details |
C13450 | BRD-K34816161 | BRD-K34816161 | -- | -- | -- | Details |
C13451 | BRD-K34817515 | fluocinolone | -- | -- | -- | Details |
C13452 | BRD-K34820100 | tebuthiuron | -- | -- | -- | Details |
C13453 | BRD-K34825242 | BRD-K34825242 | -- | -- | -- | Details |
C13454 | BRD-K34829873 | BRD-K34829873 | -- | -- | -- | Details |
C13455 | BRD-K34834946 | BRD-K34834946 | -- | -- | -- | Details |
C13456 | BRD-K34836852 | BRD-K34836852 | -- | -- | -- | Details |
C13457 | BRD-K34839715 | BRD-K34839715 | -- | -- | -- | Details |
C13458 | BRD-K34839838 | BRD-K34839838 | -- | -- | -- | Details |
C13459 | BRD-K34844610 | BRD-K34844610 | -- | -- | -- | Details |
C13460 | BRD-K34851865 | BRD-K34851865 | -- | -- | -- | Details |
C13461 | BRD-K34856675 | BRD-K34856675 | -- | -- | -- | Details |
C13462 | BRD-K34858602 | BRD-K34858602 | -- | -- | -- | Details |
C13463 | BRD-K34869284 | BRD-K34869284 | -- | -- | -- | Details |
C13464 | BRD-K34870043 | adoprazine | DRD2; HTR1A | Serotonin receptor agonist; Dopamine receptor antagonist | -- | Details |
C13465 | BRD-K34875633 | o-anisidine.hcl | -- | -- | -- | Details |
C13466 | BRD-K34886590 | BRD-K34886590 | -- | -- | -- | Details |
C13467 | BRD-K34888156 | theobromine | -- | -- | -- | Details |
C13468 | BRD-K34898196 | BRD-K34898196 | -- | -- | -- | Details |
C13469 | BRD-K34898609 | BRD-K34898609 | -- | -- | -- | Details |
C13470 | BRD-K34898990 | BRD-K34898990 | -- | -- | -- | Details |
C13471 | BRD-K34907403 | BRD-K34907403 | -- | -- | -- | Details |
C13472 | BRD-K34910830 | BRD-K34910830 | -- | -- | -- | Details |
C13473 | BRD-K34913101 | BRD-K34913101 | -- | -- | -- | Details |
C13474 | BRD-K34922409 | BRD-K34922409 | -- | -- | -- | Details |
C13475 | BRD-K34929471 | BRD-K34929471 | -- | -- | -- | Details |
C13476 | BRD-K34929727 | BRD-K34929727 | -- | -- | -- | Details |
C13477 | BRD-K34931072 | BRD-K34931072 | -- | -- | -- | Details |
C13478 | BRD-K34937870 | BRD-K34937870 | -- | -- | -- | Details |
C13479 | BRD-K34940426 | BRD-K34940426 | -- | -- | -- | Details |
C13480 | BRD-K34942615 | BRD-K34942615 | -- | -- | -- | Details |
C13481 | BRD-K34948786 | BRD-K34948786 | -- | -- | -- | Details |
C13482 | BRD-K34952911 | BRD-K34952911 | -- | -- | -- | Details |
C13483 | BRD-K34954550 | BRD-K34954550 | -- | -- | -- | Details |
C13484 | BRD-K34957967 | BRD-K34957967 | -- | -- | -- | Details |
C13485 | BRD-K34960081 | BRD-K34960081 | -- | -- | -- | Details |
C13486 | BRD-K34966059 | BRD-K34966059 | -- | -- | -- | Details |
C13487 | BRD-K34966483 | MW-STK33-3A | -- | -- | -- | Details |
C13488 | BRD-K34968258 | BRD-K34968258 | -- | -- | -- | Details |
C13489 | BRD-K34974135 | BRD-K34974135 | -- | -- | -- | Details |
C13490 | BRD-K34974324 | BRD-K34974324 | -- | -- | -- | Details |
C13491 | BRD-K34977825 | BRD-K34977825 | -- | -- | -- | Details |
C13492 | BRD-K34980742 | BRD-K34980742 | -- | -- | -- | Details |
C13493 | BRD-K34981405 | BRD-K34981405 | -- | -- | -- | Details |
C13494 | BRD-K34982474 | BRD-K34982474 | -- | -- | -- | Details |
C13495 | BRD-K34985075 | BRD-K34985075 | -- | -- | -- | Details |
C13496 | BRD-K34985200 | BRD-K34985200 | -- | -- | -- | Details |
C13497 | BRD-K34990278 | BRD-K34990278 | -- | -- | -- | Details |
C13498 | BRD-K34992378 | BRD-K34992378 | -- | -- | -- | Details |
C13499 | BRD-K34995470 | SU-1498 | ERBB2 | VEGFR inhibitor | -- | Details |
C13500 | BRD-K35001076 | BRD-K35001076 | -- | -- | -- | Details |
C13501 | BRD-K35002913 | BRD-K35002913 | -- | -- | -- | Details |
C13502 | BRD-K35004659 | BRD-K35004659 | -- | -- | -- | Details |
C13503 | BRD-K35007173 | enprofylline | ADORA2B; PDE4A | Phosphodiesterase inhibitor | -- | Details |